Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Inflammatory Bowel Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03105128
What this trial is testing

The Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 931
Not applicableStudy completedNCT03488030
What this trial is testing

Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD)

Who this might be right for
Crohn DiseaseColitis, UlcerativeInflammatory Bowel Disease
Takeda 246
Not applicableLooking for participantsNCT05428345
What this trial is testing

Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea

Who this might be right for
Ulcerative ColitisCrohn's DiseaseInflammatory Bowel Disease (IBD)
Takeda 600
Testing effectiveness (Phase 2)UnknownNCT02465944
What this trial is testing

A Pilot Study of FFP104 in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
Fast Forward Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT01466374
What this trial is testing

Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Bristol-Myers Squibb 121
Testing effectiveness (Phase 2)Ended earlyNCT01150890
What this trial is testing

Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Amgen 130
Large-scale testing (Phase 3)Study completedNCT03345849
What this trial is testing

The Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies

Who this might be right for
Crohn's Disease
AbbVie 526
Large-scale testing (Phase 3)Study completedNCT00488631
What this trial is testing

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 1,228
Large-scale testing (Phase 3)Looking for participantsNCT07196722
What this trial is testing

Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 1,092
Testing effectiveness (Phase 2)Ended earlyNCT05068284
What this trial is testing

Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 176
Post-approval studies (Phase 4)Active Not RecruitingNCT06964113
What this trial is testing

Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice

Who this might be right for
Ulcerative Colitis
Eisai Korea Inc. 94
Large-scale testing (Phase 3)Study completedNCT02039505
What this trial is testing

Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Takeda 292
Testing effectiveness (Phase 2)Active Not RecruitingNCT06257875
What this trial is testing

Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 156
Testing effectiveness (Phase 2)WithdrawnNCT03627052
What this trial is testing

Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis

Who this might be right for
Moderate to Severe Ulcerative Colitis
Incyte Corporation
Large-scale testing (Phase 3)UnknownNCT05771155
What this trial is testing

Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio®

Who this might be right for
Ulcerative Colitis
Polpharma Biologics S.A. 750
Testing effectiveness (Phase 2)Study completedNCT03558152
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Genentech, Inc. 195
Early research (Phase 1)Study completedNCT02968108
What this trial is testing

A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 45
Testing effectiveness (Phase 2)Study completedNCT01694485
What this trial is testing

Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Amgen 359
Testing effectiveness (Phase 2)Ended earlyNCT00584740
What this trial is testing

Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohn's Disease
Novartis Pharmaceuticals 59
Testing effectiveness (Phase 2)Study completedNCT01155362
What this trial is testing

PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Celularity Incorporated 50
Next Page